Abstract
In addition to DNA-based assays, molecular cytopathology includes RNA-based assays. In routine clinical settings, these assays are used for the detection of relevant biomarkers to refine indeterminate morphological diagnosis and to predict treatment response. In this chapter, we will focus on a wide range of RNA-based techniques, including conventional as well as emerging assays, such as quantitative reverse transcriptase-PCR (qRT-PCR), next-generation RNA sequencing, and multiplex digital color-coded barcode technology. We provide a brief overview of the main technical aspects of RNA workflow analysis with a focus on the potential and the challenges of cytological specimens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- ALK :
-
Anaplastic lymphoma kinase or ALK receptor tyrosine kinase
- BRAF :
-
v-Raf murine sarcoma oncogene homolog B
- DNA:
-
Deoxyribonucleic acid
- EGFR :
-
Epidermal growth factor receptor
- IVD:
-
In vitro diagnostic
- LOD:
-
Limit of detection
- MET :
-
MET proto-oncogene, receptor tyrosine kinase
- NGS:
-
Next-generation sequencing
- NRG1 :
-
Neuregulin 1
- NTRK :
-
Neurotrophic tyrosine kinase, receptor
- RET :
-
Proto-oncogene tyrosine-protein kinase receptor ret
- ROS1 :
-
ROS proto-oncogene 1, receptor tyrosine kinase
- RNA:
-
Ribonucleic acid
- RT-PCR:
-
Reverse transcription-polymerase chain reaction
- TAT:
-
Turnaround time
References
Malapelle U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Savic S, Bihl M, et al., Molecular Cytopathology Meeting Group. Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: a worldwide ring trial study on quantitative cytological molecular reference specimens. Cancer Cytopathol. 2017;125:615–26.
Clark DP. Seize the opportunity: underutilization of fine-needle aspiration biopsy to inform targeted cancer therapy decisions. Cancer. 2009;117:289–97.
Schmitt FC, Longatto-Filho A, Valent A, et al. Molecular techniques in cytopathology practice. J Clin Pathol. 2008;61:258–67.
Bellevicine C, Sgariglia R, Malapelle U, Vigliar E, Nacchio M, Ciancia G, et al. Young investigator challenge: can the ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? Cancer Cytopathol. 2016;124:776–84.
Aisner DL, Sams SB. The role of cytology specimens in molecular testing of solid tumors: techniques, limitations, and opportunities. Diagn Cytopathol. 2012;40:511–24.
Weinreb I, Bishop JA, Chiosea SI, Seethala RR, Perez-Ordonez B, Zhang L, et al. Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland. Am J Surg Pathol. 2018;42:442–52.
Dietel M, Bubendorf L, Dingemans AM, Dooms C, Elmberger G, García RC, et al. Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group. Thorax. 2016;71:177–84.
Pisapia P, Lozano MD, Vigliar E, Bellevicine C, Pepe F, Malapelle U, Troncone G. ALK and ROS1 testing on lung cancer cytologic samples: perspectives. Cancer Cytopathol. 2017;125:817–30.
Aisner DL, Rumery MD, Merrick DT, et al. Do more with less: tips and techniques for maximizing small biopsy and cytology specimens for molecular and ancillary testing: the University of Colorado experience. Arch Pathol Lab Med. 2016;140:1206–20.
Alì G, Bruno R, Savino M, Giannini R, Pelliccioni S, Menghi M, et al. Analysis of fusion genes by nanoString system: a role in lung cytology? Arch Pathol Lab Med. 2018;142:480–9.
Tazi J, Bakkour N, Stamm S. Alternative splicing and disease. Biochim Biophys Acta. 2009;1792:14–26.
Awad MM, Oxnard GR, Jackman DM, Savukoski DO, Hall D, Shivdasani P, et al. MET exon 14 mutations in non-small-cell lung cancer are associated with advanced age and stage-dependent MET genomic amplification and c-met overexpression. J Clin Oncol. 2016;34:721–30.
Fink L, Seeger W, Ermert L, Hänze J, Stahl U, Grimminger F, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med. 1998;4:1329–33.
Malapelle U, Mayo de-Las-Casas C, Rocco D, Garzon M, Pisapia P, Jordana-Ariza N, et al. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients. Br J Cancer. 2017;116:802–10.
Sgariglia R, Pisapia P, Nacchio M, De Luca C, Pepe F, Russo M, et al. Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study. J Clin Pathol. 2017;70:803–6.
Bellevicine C, Malapelle U, Vigliar E, Pisapia P, Vita G, Troncone G. How to prepare cytological samples for molecular testing. J Clin Pathol. 2017;70:819–26.
Bridge JA. Reverse transcription-polymerase chain reaction molecular testing of cytology specimens: pre-analytic and analytic factors. Cancer. 2017;125:11–9.
Dejmek A, Zendehrokh N, Tomaszewska M, Edsjö A. Preparation of DNA from cytological material: effects of fixation, staining, and mounting medium on DNA yield and quality. Cancer Cytopathol. 2013;121:344–53.
Ladd AC, O’Sullivan-Mejia E, Lea T, Perry J, Dumur CI, Dragoescu E, et al. Preservation of fine-needle aspiration specimens for future use inRNA-based molecular testing. Cancer Cytopathol. 2011;119:102–10.
Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E, et al. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res. 2005;33:e56.
Skrypina NA, Timofeeva AV, Khaspekov GL, Savochkina LP, Beabealashvilli RS. Total RNA suitable for molecular biology analysis. J Biotechnol. 2003;105:1–9.
Wilkes TM, Devonshire AS, Ellison SL, Foy CA. Evaluation of a novel approach for the measurement of RNA quality. BMC Res Notes. 2010;3:89.
Zhang Y, Ni M, Liu N, Zhou Y, Chen X, Ding YB, et al. Expression and function of Pdcd4 in mouse endometrium during early pregnancy. Reproduction. 2018. pii: REP-17-0787.
Attri KS, Mehla K, Shukla SK, Singh PK. Microscale gene expression analysis of tumor-associated macrophages. Sci Rep. 2018;8:2408.
Wang J, Yao A, Wang JY, Sung CC, Fink LM, Hardin JW, Hauer-Jensen M. cDNA cloning and sequencing, gene expression, and immunolocalization of thrombomodulin in the Sprague-Dawley rat. DNA Res. 1999;6:57–62.
Ruiz-Villalba A, van Pelt-Verkuil E, Gunst QD, Ruijter JM, van den Hoff MJ. Amplification of nonspecific products in quantitative polymerase chain reactions (qPCR). Biomol Detect Quantif. 2017;14:7–18.
Reguart N, Teixidó C, Giménez-Capitán A, Paré L, Galván P, Viteri S, et al. Identification of ALK, ROS1, and RET fusions by a multiplexed mRNA-based assay in formalin-fixed, paraffin-embedded samples from advanced non-small-cell lung Cancer patients. Clin Chem. 2017;63:751–60.
Oktay MH, Adler E, Hakima L, Grunblatt E, Pieri E, Seymour A, et al. The application of molecular diagnostics to stained cytology smears. J Mol Diagn. 2016;18:407–15.
Mitiushkina NV, Iyevleva AG, Poltoratskiy AN, Ivantsov AO, Togo AV, Polyakov IS, et al. Detection of EGFR mutations and EML4-ALK rearrangements in lung adenocarcinomas using archived cytological slides. Cancer Cytopathol. 2013;121:370–6.
Ferraz C, Rehfeld C, Krogdahl A, Precht Jensen EM, Bösenberg E, Narz F, et al. Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Thyroid. 2012;22:1025–30.
Jennings LJ, Arcila ME, Corless C, et al. Guidelines for validation of next-generation sequencing-based oncology panels: a joint consensus recommendation of the Association for Molecular Pathology and College of American Pathologists. J Mol Diagn. 2017;19:341–65.
Clinical and Laboratory Standards Institute. Nucleic acid sequencing methods in diagnostic laboratory medicine; approved guideline. (CLSI document MM09-A2). 2nd ed. Wayne: Clinical and Laboratory Standards Institute; 2014.
Bentley DR, Balasubramanian S, Swerdlow HP, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008;456:53–9.
Arvidsson G, Henriksson J, Sander B, Wright AP. Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients. Haematologica. 2018;103:666–78.
Hynes SO, Pang B, James JA, et al. Tissue-based next generation sequencing: application in a universal healthcare system. Br J Cancer. 2017;116:553–60.
Head SR, Komori HK, LaMere SA, Whisenant T, Van Nieuwerburgh F, Salomon DR, Ordoukhanian P. Library construction for next-generation sequencing: overviews and challenges. Biotechniques. 2014;56:61–4, 66, 68, passim.
Etheridge A, Wang K, Baxter D, Galas D. Preparation of small RNA NGS libraries from biofluids. Methods Mol Biol. 2018;1740:163–75.
Velizheva NP, Rechsteiner MP, Wong CE, Zhong Q, Rössle M, Bode B, et al. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung. Cancer Cytopathol. 2017;125:30–40.
Guseva NV, Jaber O, Stence AA, Sompallae K, Bashir A, Sompallae R, et al. Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assay. Cancer Cytopathol. 2018;126:158–69.
Troncone G. All-in-one: the dream and reality of molecular cytopathology testing on routine lung cancer smears. Cancer Cytopathol. 2018;126:155–7.
Kim MH, Seo HJ, Joung JG, Kim JH. Comprehensive evaluation of matrix factorization methods for the analysis of DNA microarray gene expression data. BMC Bioinformatics. 2011;12 Suppl 13:S8.
Lira ME, Choi YL, Lim SM, Deng S, Huang D, Ozeck M, et al. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer. J Mol Diagn. 2014;16:229–43.
Lira ME, Kim TM, Huang D, Deng S, Koh Y, Jang B, et al. Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer. J Mol Diagn. 2013;15:51–61.
Sunami K, Furuta K, Tsuta K, Sasada S, Izumo T, Nakaoku T, et al. Multiplex diagnosis of oncogenic fusion and MET exon skipping by molecular counting using formalin-fixed paraffin embedded lung adenocarcinoma tissues. J Thorac Oncol. 2016;11:203–12.
Zhao W, Choi YL, Song JY, Zhu Y, Xu Q, Zhang F, et al. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare. Lung Cancer. 2016;94:22–7.
Fang DD, Zhang B, Gu Q, Lira M, Xu Q, Sun H, et al. HIP1-ALK, a novel ALK fusion variant that responds to crizotinib. J Thorac Oncol. 2014;9:285–94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Malapelle, U., Pisapia, P., Cieri, M., Pepe, F., Troncone, G. (2019). RNA-Based Assays. In: Roy-Chowdhuri, S., VanderLaan, P., Stewart, J., Santos, G. (eds) Molecular Diagnostics in Cytopathology. Springer, Cham. https://doi.org/10.1007/978-3-319-97397-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-97397-5_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-97396-8
Online ISBN: 978-3-319-97397-5
eBook Packages: MedicineMedicine (R0)